Long-Term Efficacy of High-Dose Imatinib in Hispanic Patients Without Access to Second-Generation Tyrosine Kinase Inhibitors Treated in LATAM Centers

Autor:	Cantu-Rodriguez, Olga Graciela, Osorno-Rodriguez, Karen Lorena, Dorsey-Trevino, Edgar Gerardo, Gutierrez-Aguirre, Cesar Homero, Jaime-Perez, Jose Carlos, Gomez-Villarreal, Juan Pablo, Rios-Rodelo, Miguel Ricardo, Gonzalez-Cantu, Graciela Alejandra, Contreras-Arce, Alan, Colunga-Pedraza, Perla Rocio, Gomez-De Leon, Andres, Mancias-Guerra, Maria del Consuelo, Tarin-Arzaga, Luz del Carmen, Gomez-Almaguer, David
Zdroj:	In Clinical Lymphoma, Myeloma and Leukemia November 2023 23(11):e386-e392
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect